Platelet Modulation in the Control of Angiogenesis: The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Activation and Angiogenic Proteins
Observational
N/A
Angiogenic Protein levels
following 6 months of therapy
No
Chris E Holmes, MD, PhD
Principal Investigator
University of Vermont
United States: Institutional Review Board
V0805
NCT01341171
August 2009
September 2012
Name | Location |
---|---|
University Of Vermont | Burlington,, Vermont 05403 |